Modulation of Ia+ Langerhans cell numbers in vivo by cultured epidermis derived supernatants and by GM-CSF

Exp Dermatol. 1996 Feb;5(1):28-37. doi: 10.1111/j.1600-0625.1996.tb00090.x.

Abstract

This paper demonstrates that epidermal cells in culture produce an activity which can increase the frequency of Ia+ epidermal Langerhans cells (LC). This was achieved by treating mice topically with a mixture containing supernatant derived from primary culture of murine epidermis (ES) and a synthetic corticosteroid, triamcinolone acetonide (TAC). The presence of the supernatant in the mixture partially protected the Ia+ LC from depletion by the steroid. The Ia+ LC frequency increasing activity was measured as the difference between the Ia+ LC frequency due to treatment with steroid mixed with supernatant and the Ia+ LC frequency due to treatment with steroid mixed with negative control medium. The mean frequency of Ia+ LC in epidermis treated with TAC mixed with ES was 606(SD 43) cells/mm2, as compared with 486 (SD 68) cells/mm2 in the epidermis treated with TAC mixed with control medium. The activity appeared to be caused by (a) proteinaceous factor(s). A fraction of ES which was retained above a > or = 10 KDa molecular weight cut-off membrane was capable of partially protecting Ia+ LC frequency from TAC depletion. Supernatants from cultured lymph nodes, dermis as well as the squamous cell carcinoma lines T7 and T79, but not the human osteosarcoma cell-line 143B, also contained similar activities. We demonstrate that GM-CSF also increased the number of Ia+ epidermal LC when applied topically to mouse skin in this system. Therefore, using this Ia+ LC frequency modulation system, we propose that GM-CSF is one example of a cytokine which may be involved in the regulation of Ia+ LC numbers in epidermis and that epidermal cells produce factors which can increase the number of Ia+ LC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Neoplasms / metabolism
  • Bone Neoplasms / pathology
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cell Count / drug effects
  • Cells, Cultured
  • Culture Media, Conditioned / pharmacology*
  • Epidermal Cells
  • Epidermis / metabolism*
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Histocompatibility Antigens Class II*
  • Langerhans Cells / drug effects*
  • Lymph Nodes / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Osteosarcoma / metabolism
  • Osteosarcoma / pathology
  • Recombinant Proteins / pharmacology
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology
  • Triamcinolone Acetonide / pharmacology
  • Tumor Cells, Cultured

Substances

  • Culture Media, Conditioned
  • Histocompatibility Antigens Class II
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Triamcinolone Acetonide